HAVN Life Sciences Inc 5NP0.BE
HAVN Life Sciences Inc. Stock Analysis 5NP0.BE
Germany N/A Nano Cap HAVN Life Sciences, Inc. is a biotechnology company, which provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions. The company is headquartered in Port Moody, British Columbia. The company went IPO on 2020-09-08. The firm is focused on standardizing the extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities of the mind. HAVN Labs is engaged in the development of its first psilocybin grow in Jamaica and will operate from its research facility in Vancouver. HAVN Labs will provide standardized psychedelic compound formulations for academic institutions with isolates and extractions from its facility that will be utilized for clinical trials and as active pharmaceutical ingredients for products. HAVN Retail is engaged in the expansion of distribution channels. Its products include Bacopa Brain, Reishi Recharge, Cordyceps Perform, Lion's Mane, Rhodiola Relief, among others. The company offers a full range of mushroom and plant extracts that help boost immune function, reduce inflammation, and support a healthy lifestyle.
Read More HAVN Life Sciences Inc (5NP0.BE) Chart
Key Statistics of HAVN Life Sciences Inc (5NP0.BE)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Open
-Volume
-P/E Ratio (TTM)
-Financial Metrics & Statements of HAVN Life Sciences Inc (5NP0.BE)
Super Investors Invested in HAVN Life Sciences Inc (5NP0.BE)
FAQ's for HAVN Life Sciences Inc (5NP0.BE)
- As of July 2026, HAVN Life Sciences Inc 5NP0.BE is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes HAVN Life Sciences Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in HAVN Life Sciences Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of HAVN Life Sciences Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of HAVN Life Sciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of HAVN Life Sciences Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.